In this study, we attempted to demonstrate the potential effect of ramucirumab and TGF‐β receptor inhibitor on tumor invasiveness and PDC‐induced angiogenesis in diffuse‐type GC cell line and PCD models. This evidence concerns the gene PDC and neoplasm.